Qiagen's HPV Test Patent Not Infringed: Fed. Circ.

Law360, New York (April 1, 2009, 12:00 AM EDT) -- A federal appeals court has upheld a district court’s finding that Third Wave Technologies Inc. did not infringe Qiagen NV unit Digene Corp.’s patent covering a test for the cancer-causing human papillomavirus, as well as the court's dismissal of Third Wave’s antitrust cross-claims.

The U.S. Court of Appeals for the Federal Circuit on Wednesday determined that the U.S. District Court for the Western District of Wisconsin did not err in its claim constructions that deflated Qiagen’s patent case and was correct in granting Qiagen summary judgment...
To view the full article, register now.